Can tramadol cause vertigo as a side effect?

Does Tramadol Cause Vertigo?

Yes, tramadol commonly causes vertigo and dizziness as recognized adverse effects, with clinical trials documenting vertigo/dizziness in 26-33% of patients within the first 90 days of treatment. 1

Evidence from FDA Drug Labeling

The FDA-approved prescribing information for tramadol explicitly identifies dizziness/vertigo as one of the most frequent adverse reactions:

• Dizziness/vertigo occurred in 26% of patients within 7 days, 31% by 30 days, and 33% by 90 days in chronic pain trials 1
• Dizziness/vertigo was the most commonly reported adverse reaction in these studies, even more frequent than nausea 1
• A clinical titration study specifically demonstrated that slower dose escalation (50 mg increments every 3 days to reach 200 mg daily) resulted in fewer discontinuations due to dizziness or vertigo compared to faster titration schedules 1

Supporting Evidence from Clinical Guidelines

Multiple clinical practice guidelines confirm vertigo as a significant tramadol-associated adverse effect:

• ESMO (European Society for Medical Oncology) guidelines report that tramadol produced "a significant major incidence of nausea, vomiting, vertigo, anorexia and asthenia" compared to hydrocodone in randomized controlled trials 2
• NCCN (National Comprehensive Cancer Network) guidelines note that tramadol produces "more adverse effects, including vomiting, dizziness, and weakness" than hydrocodone and codeine in double-blind cancer pain studies 3, 4

Clinical Research Findings

Recent research corroborates these findings across multiple patient populations:

• A 2007 osteoarthritis study identified dizziness/vertigo as a typical adverse event with tramadol, occurring with mild to moderate intensity in 87% of affected patients 5
• A 2000 comparative study found that vertigo and perspiration were reported more frequently after tramadol (58% and 78%) than after tilidine/naloxone (8%) 6
• A 1999 titration study demonstrated that slower tramadol initiation significantly reduced discontinuations due to dizziness/vertigo, establishing this as a dose-dependent and titration-sensitive adverse effect 7
• A 2024 Japanese multicenter study reported dizziness in 1.9% of chronic low back pain patients treated with tramadol 8
• A 2023 pharmacovigilance analysis of Dutch national data confirmed dizziness as the second most reported adverse reaction with tramadol (after nausea) 9

Mechanism and Clinical Implications

The vertigo associated with tramadol likely relates to its dual mechanism of action involving both opioid receptor agonism and monoamine reuptake inhibition (norepinephrine and serotonin) 1

Key clinical considerations:

• Vertigo risk is highest during initial dosing and dose escalation 1, 7
• Gradual titration (50 mg increments every 3 days) significantly improves tolerability and reduces vertigo-related discontinuations 1, 7
• The maximum recommended daily dose is 400 mg for immediate-release or 300 mg for extended-release formulations in adults with normal hepatic and renal function 4
• Lower doses are recommended for adults ≥75 years and those with hepatic or renal dysfunction to reduce adverse effects including vertigo 4

Risk Mitigation Strategy

To minimize vertigo when prescribing tramadol:

• Start with 25-50 mg doses rather than the standard 50-100 mg 4
• Increase by 50 mg increments every 3 days until reaching the target therapeutic dose 1, 7
• Counsel patients that vertigo is common (occurring in approximately one-quarter to one-third of patients) but often improves with continued use 1
• Consider alternative analgesics (morphine, oxycodone, hydrocodone, or non-opioid options) in patients who cannot tolerate the vestibular effects 4